Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Smoak Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
YTD-4.35%
Annualized+40.5%
Positioning StanceConstructive
Market CapSmallCap
Digest Analysis
Quick Take
"Lagging the S&P 500's 10.2% as AI stocks dominated. The manager deliberately avoids AI, focusing instead on severely undervalued Korean and Japanese small caps improving capital allocation."
Executive Summary
Smoak Capital returned -4.35% net in 1H 2026 versus the S&P 500's 10.2% gain, with underperformance driven by the manager's deliberate avoidance of AI-related stocks that powered most of the index's return. The manager views AI as in the too-hard pile and instead focuses on undervalued small-cap opportunities in South Korea and Japan. South Korea's comprehensive market reforms, including mandatory treasury share cancellation, expanded fiduciary duties, and high dividend tax incentives, are driving meaningful capital allocation improvements, though closing the Korea Discount will take years. Top performers included InBody, a Korean body composition device leader benefiting from GLP-1 adoption, trading at only 7.6x EV/2026e EBIT despite 86% YoY operating income growth, and QEPC, which was sold near fair value. Worst performers included Azeus Systems and PHI Group, though the manager remains comfortable holding both as undervalued with strong fundamentals. The fund has delivered 34% annualized returns since inception versus 15.3% for the S&P 500, turning $100,000 into over $1 million. The manager expects continued focus on undervalued small caps committed to capital allocation improvements.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
78%
CautiousHigh
High Conviction (78%)
The manager demonstrates high conviction through concentrated discussion of specific named positions (InBody, M-up Holdings) with detailed fundamental analysis, explicit valuation targets (7.6x EV/EBIT for InBody, 7.8x EV/fwdFCF for M-up), and clear position sizing language (InBody was the fund's strongest performer). The letter includes multi-page deep dives on two holdings with specific financial metrics, growth drivers, and competitive positioning. The manager also shows conviction through explicit avoidance of AI despite underperformance, stating it remains in the too-hard pile. However, the fund appears to hold 10-20 positions based on the discussion of multiple holdings, preventing a score above 0.85.
Growth Outlook
35%
BearishBullish
Bearish (35%)
The manager acknowledges AI stocks have powered the S&P 500's YTD return and notes growth stocks in North America and Europe trade at expensive multiples, suggesting caution about developed market valuations. However, the manager sees many undervalued opportunities in South Korea and Japan, with specific positive commentary about Korean market reforms creating a re-evaluation opportunity. The outlook is mildly constructive on select markets (Asia) while cautious on others (US/Europe), landing in mildly positive territory.
Risk Appetite
45%
DefensiveAggressive
Balanced (45%)
The manager is actively deploying capital into undervalued small-cap Korean and Japanese names, with detailed discussion of new positions like InBody and M-up Holdings. However, the manager is also explicitly avoiding the AI-related stocks that have driven most market gains, and sold QEPC near fair value citing opportunity cost. This represents selective risk-taking in specific geographies and market caps while avoiding the dominant market theme, indicating a moderately positive but selective risk posture.
Capital Deployment
25%
De-riskingDeploying
De-risking (25%)
The manager sold QEPC as it approached fair value, representing capital harvesting. However, the letter discusses active focus on undervalued Korean and Japanese small caps with detailed analysis of new or existing positions like InBody and M-up Holdings, suggesting selective deployment. No specific cash level changes are stated. The net activity appears to be rotation from fair value positions into undervalued opportunities rather than aggressive net deployment or de-risking, landing near neutral with a slight positive tilt.
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
The manager states clear intent to continue focusing on undervalued small-cap opportunities in South Korea and Japan committed to capital allocation improvements. The letter describes actively seeking companies with Value-Up disclosures and severe undervaluation. While the manager acknowledges closing the Korea Discount will take years, there is explicit forward deployment bias toward these specific opportunities. This represents moderate selective deployment rather than broad market participation.
Language Signal
40%
BearishBullish
Balanced (40%)
The letter contains substantial opportunity language around undervalued, materially undervalued, absurdly cheap, and severe undervaluation in Korean and Japanese small caps. However, this is balanced by risk language around AI disruption fears, expensive multiples in developed markets, and the fund's underperformance. The manager uses phrases like too-hard pile for AI and acknowledges headwinds. The net balance leans moderately positive given the emphasis on specific opportunities, but the risk acknowledgment prevents a higher score.
Perceived Risk
55%
Low RiskElevated
Moderate Risk (55%)
The manager identifies several specific risks: AI-related stocks dominating market returns and contributing to underperformance, expensive multiples in developed market growth stocks, AI disruption fears affecting software companies, and the multi-year timeline required to close the Korea Discount. The letter acknowledges wild swings in the KOSPI due to concentration in AI-exposed names. However, these risks are discussed in measured terms without alarm, and the manager expresses confidence in the differentiated risk profile of holdings like M-up and Azeus versus vulnerable enterprise SaaS platforms. This represents moderate risk acknowledgment without systemic concern.
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
The manager sees abundant opportunities in specific markets, stating South Korea and Japan present many undervalued opportunities and that undervalued Korean names seem painfully ignored. The letter describes InBody as absurdly cheap (EV/EBIT of 5 or less) and M-up as completely disconnected from business quality. However, the manager also notes growth stocks in North American and European markets continue to trade at expensive multiples, limiting the opportunity set in developed markets. The overall assessment is selective abundance in Asia but scarcity in developed markets, landing in the moderately high range.
Time Horizon
72%
Short-TermLong-Term
Decade+ (72%)
The manager explicitly states that closing the Korea Discount will take years and continued commitment, indicating a multi-year thesis. The letter emphasizes patience, focus, and a process-oriented mindset for long-term outperformance. The manager is comfortable holding positions like Azeus and PHI Group through near-term headwinds and discusses M-up's long-term growth potential without near-term catalyst dependency. However, the letter also references quarterly results and near-term performance metrics, and sold QEPC based on proximity to fair value, suggesting some medium-term orientation. This represents a multi-year but not permanent capital horizon.